Back

Optum Health Education

  • Liquid Biopsy
  • Neoplastic Cells, Circulating

Liquid Biopsies: Continuing to Revolutionize Early Cancer Detection

Advancements in blood testing for early cancer detection, aka liquid biopsy, offer potentially earlier and less-invasive cancer detection and include those focused on circulating tumor DNA (ctDNA), circulating tumor cells (CTCs) and protein biomarkers, among others. Through an exploration of current research, clinical trials, and current and emerging real-world applications, participants will gain a comprehensive understanding of the benefits, challenges, and clinical implications of these cutting-edge diagnostic tools that are transforming the future of early cancer detection and care.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.75 creditsAMA PRA Category 1 Credit™Up to 0.75 creditsDietetic CPEUsUp to 0.75 creditsNursingUp to 0.75 creditsPharmacyUp to 0.75 creditsPsychologyUp to 0.75 creditsSocial WorkUp to 0.75 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 0.75 credits
  • Released
    Jun 11, 2024
  • Last day to claim credit
    Jun 12, 2027 8 months left